Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2002

View Archived Issues

Bay-41-4109: a novel anti-HBV candidate

Cannabinoids may not improve symptoms of multiple sclerosis

Safe transition from i.v. epoprostenol to s.c. treprostinil in patients with PAH

Therapeutic angiogenic effects of rFGF-2 in patients with intermittent claudication

CVT-3146 set to enter phase III in 2003

Eligix CD8-SC Cell Separation System approved in E.U.

Fujisawa announces microbial research agreement with MerLion

Fujirebio acquires rights to ovarian tumor markers

Amersham Biosciences and Sloan-Kettering Institute collaborate to scan human genome

Immune Network and AbNovo to develop antibody-based therapeutics for viral diseases

Levaquin sNDA submitted for chronic bacterial prostatitis

Incara's IND for liver cell therapy approved

Zonagen awarded SBIR grant for Progenta in breast cancer

Bristol-Myers Squibb researchers identify CDK-inhibitory semicarbazides

Japanese, American and British scientists jointly describe new PI3K inhibitors

New CDK inhibitors in early development at BMS

Roche presents A2A antagonists with potential in depression and other disorders

Versicor and Biosearch Italia to merge

Aventis describes novel factor Xa/VIIa inhibitors and their use

Novel tryptase inhibitors emerge from Boehringer Ingelheim

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...